Latest LEAD updates
Tokyo meeting explores new pathways for antimicrobial innovation
A global meeting in Tokyo has set out a more coordinated, system-wide vision for strengthening antimicrobial research and development (R&D), bringing together researchers, policymakers, and industry leaders to address persistent challenges in the field.
"We can achieve even greater progress through deeper and more strategic collaboration"
Dr. Manabu Sumi, Director-General of the Infectious Disease Prevention and Control Department, Ministry of Health, Labour and Welfare, Japan, calls for bold innovation strengthened through robust partnerships to tackle the challenges facing efforts to develop new antimicrobials.
Global leader on AMR calls for an international coalition built on credible, sustained political commitment.
Mr Yasuhisa Shiozaki, former Minister of Health, Labour and Welfare, Japan, calls for an international coalition to renew and advance antimicrobial innovation.
What partnerships are needed to ramp up the development of low-cost antimicrobial drugs?
As antimicrobial resistance continues to outpace innovation, AMR exposes a fundamental market failure with global consequences. LEAD core team member and IDS Research Fellow, Professor Gerry Bloom, highlights that addressing it will require not just scientific breakthroughs, but it demands new forms of collaboration across governments, industry, funders and civil society. This is a global issue, and it needs global collaboration.